生物技术与制药领域的最新动态
What Thermo Fisher Scientific (TMO)'s FDA Clearance for EXENT System Means for Shareholders - simplywall.st
Thermo Fisher Scientific Opens East Coast Collaboration Center at BioLabs - citybiz
Thermo Fisher targets early-stage CGT bottlenecks with new Philadelphia hub - R&D World
Monster Beverage, UnitedHealth, Thermo Fisher Scientific And More: CNBC's 'Final Trades' - Benzinga
The Zacks Analyst Blog Highlights NVIDIA, Micron Technology and Thermo Fisher Scientific - Nasdaq
If You Invested $1000 in Thermo Fisher Scientific 10 Years Ago, This Is How Much You'd Have Now - Nasdaq
Rx Rundown: Metagenomi, Chiesi, Thermo Fisher Scientific and more - Medical Marketing and Media
Thermo Fisher Scientific Receives 510(k) Clearance in the United States for EXENT System* to Aid in the Diagnosis of Multiple Myeloma - BioSpace
Finalists in the Thermo Fisher JIC explore biomimicry with SERC - societyforscience.org
Thermo Fisher Scientific (TMO): Evaluating Valuation After $5 Billion Share Buyback Announcement - simplywall.st
Thermo Fisher Scientific Debuts Orbitrap Exploris EFOX Mass Detector - Food Engineering Mag
Thermo Fisher Unveils $5 Billion Buyback, Keeps Dividend Intact - Yahoo Finance
Why Thermo Fisher Scientific Stock Jumped 40%? - Trefis
Thermo Fisher Scientific Authorizes $5 Billion of Share Repurchases - Business Wire
Thermo Fisher Scientific declares $0.43 quarterly dividend - Investing.com
Thermo Fisher Scientific Declares Quarterly Dividend payable on January 15, 2026 - BioSpace
Thermo Fisher Scientific Authorizes $5 Billion of Share Repurchases - BioSpace
How Investors Are Reacting To Thermo Fisher Scientific (TMO) Product Launches and Strong Quarterly Results - simplywall.st
Thermo Fisher Scientific Shows Improved Relative Price Performance; Still Shy Of Benchmark - Investor's Business Daily
Thermo Fisher Expands Biopharma Offerings With $9B Deal for Clinical Trial Software Firm Clario - MedCity News